Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Kala-Azar Dermal Leishmaniasis”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Post-approval studies (Phase 4)Study completedNCT01975051
What this trial is testing

Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 36
Not applicableNot Yet RecruitingNCT07506967
What this trial is testing

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Who this might be right for
Skin and Connective Tissue DiseasesNeglected Tropical DiseasesLeprosy+10 more
Kenya Medical Research Institute 2,420
Testing effectiveness (Phase 2)Study completedNCT01635777
What this trial is testing

Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)

Who this might be right for
PKDL
AB Foundation 37
Testing effectiveness (Phase 2)WithdrawnNCT04107961
What this trial is testing

Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
University of York
Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Early research (Phase 1)Study completedNCT00982774
What this trial is testing

Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
Access to Advanced Health Institute (AAHI) 42
Very early researchStudy completedNCT07286604
What this trial is testing

Ivermectin Repurposed for the Treatment of PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 10
Testing effectiveness (Phase 2)UnknownNCT03399955
What this trial is testing

Short Course Regimens for Treatment of PKDL (Sudan)

Who this might be right for
PKDL - Post-Kala-Azar Dermal Leishmanioid
Drugs for Neglected Diseases 110
Large-scale testing (Phase 3)Study completedNCT02193022
What this trial is testing

Miltefosine for Children With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Early research (Phase 1)Study completedNCT00486382
What this trial is testing

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Who this might be right for
Visceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis
Access to Advanced Health Institute (AAHI) 36
Testing effectiveness (Phase 2)Study completedNCT03969134
What this trial is testing

Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL

Who this might be right for
Leishmaniasis, Cutaneous
University of York 86
Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Very early researchStudy completedNCT06251739
What this trial is testing

Repurposing Ivermectin for PKDL Treatment

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 30